Organization (Hospital)
Clalit Health Services
ClinicalTrials.gov lists Clalit Health Services as lead sponsor of 555 trials, counting the companies grouped under it. Clalit Health Services itself has 5 approved assets.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials started per year with this organization as sponsor or collaborator, 1990 onward. Companies grouped under this one are not included. The series also counts trials where the organization is a collaborator; the lead-sponsor trial count does not.
2026 is partial: 1 registered with a 2026 start date. The dashed outline is the pace from the 1 registered with a start date through September, planned starts included, not adjusted; not a forecast. No forecast is made for this organization: it averages 1.6 trial starts a year over the five years to September, under the 5 a year the method needs.
This page covers Clalit Health Services and 4 companies grouped under it: 555 lead-sponsored trials (44 its own, 511 in the grouped companies) and 5 legal-entity registrations (1 its own, 4 in the grouped companies).
Companies grouped under this page (4)
Shown in this order: most lead trials first.
| Company | Lead trials | Legal entities |
|---|---|---|
| Rabin Medical Center | 393 | 1 |
| Shalvata Mental Health Center | 73 | 1 |
| Kaplan Medical Center | 37 | 1 |
| Geha Mental Health Center | 8 | 1 |
Disease areas (337)
Shown in this order: most trials first.
| Disease area | Trials |
|---|---|
| Diabetes Mellitus | 68 |
| Diabetes Mellitus, Type 1 | 43 |
| Pain | 22 |
| Schizophrenia | 20 |
| Attention Deficit Disorder with Hyperactivity | 16 |
Showing 5 of 337 disease areas.
Trials by start year as sponsor or collaborator (24)
Shown in this order: most recent first. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
Show the table of trials by start year as sponsor or collaborator
| Year | Trials started |
|---|---|
| 2026 (partial year) | 1 |
| 2025 | 2 |
| 2024 | 2 |
| 2023 | 2 |
| 2022 | 1 |
| 2021 | 1 |
| 2020 | 2 |
| 2019 | 4 |
| 2018 | 4 |
| 2017 | 5 |
Showing 10 of 24 years.
Recruitment duration, a model prediction: 2 trials still running at the 2026-10-09 snapshot, fewer than the 5 needed for a median. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
Approved assets (5)
Shown in this order: max phase first.
| Drug | Trials |
|---|---|
| 25 OH vitamin D | 1 |
| Oral vitamin D 100,000 IU | 1 |
| carbocisteine cough syrup | 1 |
| ADALIMUMAB | 1 |
| Amoxicillin | 1 |
Sponsor delivery record (1)
Enrollment hit target: the share of this sponsor's lead-sponsored trials whose actual enrollment reached the planned enrollment. On time: the share whose actual primary completion date was no later than the planned date. Each share counts only trials where we observed an estimated figure before the actual one, and n is that number of trials. Below 5 trials the count is shown as a fraction, not a percentage.
| Enrollment | Timeline |
|---|---|
| 0 of 4 hit target (n=4) | 60% on time (n=5) |
Journals published in (558)
Shown in this order: most published in first.
| Journal | Publications |
|---|---|
| The Cochrane database of systematic reviews | 21 |
| Anesthesia and analgesia | 20 |
| The New England journal of medicine | 20 |
| Anesthesiology | 18 |
| Circulation | 17 |
Showing 5 of 558 journals.
Organization relationships (63)
Shown in this order: most evidence first.
| Related organization | Relationship | Evidence |
|---|---|---|
| Soroka University Medical Center | Co sponsors trial with | 8 |
| Sheba Medical Center | Co sponsors trial with | 7 |
| Tel Aviv Sourasky Medical Center | Co sponsors trial with | 7 |
| Hadassah Medical Organization | Co sponsors trial with | 7 |
| Meir Medical Center | Co sponsors trial with | 6 |
Showing 5 of 63 relationships.
Latest dated events (646)
Shown in this order: newest first.
| Date | Event | Source |
|---|---|---|
| 2027-01 | Trial started | Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI)) |
| 2026-10-05 | Trial started | Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI)) |
| 2026-07-30 | Trial started | Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI)) |
| 2026-07-01 | Trial started | Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI)) |
| 2026-06 | Trial started | Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI)) |
Showing 5 of 646 events.
Biomarker capability evidence (54)
Shown in this order: tier desc, then gene symbol.
| Gene | Role | Evidence |
|---|---|---|
| DCD | Trial sponsor | Named in trial inclusion criteria |
| EGFR | Trial collaborator | Named in trial inclusion criteria |
| ERVK-10 | Trial collaborator | Named in trial inclusion criteria |
| ERVK-18 | Trial collaborator | Named in trial inclusion criteria |
| ERVK-19 | Trial collaborator | Named in trial inclusion criteria |
Showing 5 of 54 evidence rows.
Biomarkers this organization publishes on (388)
Shown in this order: most publications first.
Showing 5 of 388 biomarkers.
Not on this page
Checked, with nothing recorded for this organization: related companies not grouped here, active development programs, us granted patents, sec-reported annual financials, financing and grant events, fda warning letters, fda untitled letters, fda inspection record, fda recalls, fda import refusals, manufacturing and distribution sites, climate targets, as filed, workforce and board diversity, as filed, and clia clinical laboratory certificates.